The Canadian Network for Observational Drug Effect Studies (CNODES): Reflections on the first eight years, and a look to the future

被引:11
作者
Platt, Robert W. [1 ,2 ,3 ]
Henry, David A. [4 ,5 ,6 ]
Suissa, Samy [1 ,2 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada
[2] Jewish Gen Hosp, Lady Davis Res Inst, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada
[4] Bond Univ, Gold Coast, Australia
[5] Univ Melbourne, Melbourne, Vic, Australia
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
pharmacoepidemiology; distributed networks; MODELS;
D O I
10.1002/pds.4936
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:103 / 107
页数:5
相关论文
共 21 条
  • [1] Developing the Sentinel System - A National Resource for Evidence Development
    Behrman, Rachel E.
    Benner, Joshua S.
    Brown, Jeffrey S.
    McClellan, Mark
    Woodcock, Janet
    Platt, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 498 - 499
  • [2] Contour plot assessment of existing meta-analyses confirms robust association of statin use and acute kidney injury risk
    Chevance, Aurelie
    Schuster, Tibor
    Steele, Russell
    Ternes, Nils
    Platt, Robert W.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (10) : 1138 - 1143
  • [3] Design considerations, architecture, and use of the Mini-Sentinel distributed data system
    Curtis, Lesley H.
    Weiner, Mark G.
    Boudreau, Denise M.
    Cooper, William O.
    Daniel, Gregory W.
    Nair, Vinit P.
    Raebel, Marsha A.
    Beaulieu, Nicolas U.
    Rosofsky, Robert
    Woodworth, Tiffany S.
    Brown, Jeffrey S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 23 - 31
  • [4] Likelihood ratio meta-analysis: New motivation and approach for an old method
    Dormuth, Colin R.
    Filion, Kristian B.
    Platt, Robert W.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2016, 47 : 259 - 265
  • [5] Data variability across Canadian administrative health databases: Differences in content, coding, and completeness
    Doyle, Carla M.
    Lix, Lisa M.
    Hemmelgarn, Brenda R.
    Paterson, J. Michael
    Renoux, Christel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 68 - 77
  • [6] Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
    Filion, Kristian B.
    Chateau, Dan
    Targownik, Laura E.
    Gershon, Andrea
    Durand, Madeleine
    Tamim, Hala
    Teare, Gary F.
    Ravani, Pietro
    Ernst, Pierre
    Dormuth, Colin R.
    [J]. GUT, 2014, 63 (04) : 552 - 558
  • [7] Common Models, Different Approaches
    Gagne, Joshua J.
    [J]. DRUG SAFETY, 2015, 38 (08) : 683 - 686
  • [8] Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article
    Gamble, J. M.
    Traynor, Robyn L.
    Gruzd, Anatoliy
    Mai, Philip
    Dormuth, Colin R.
    Sketris, Ingrid S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 93 - 102
  • [9] Reproducing Protocol-Based Studies Using Parameterizable Tools-Comparison of Analytic Approaches Used by Two Medical Product Surveillance Networks
    Huang, Ting-Ying
    Welch, Emily C.
    Shinde, Mayura U.
    Platt, Robert W.
    Filion, Kristian B.
    Azoulay, Laurent
    Maro, Judith C.
    Platt, Richard
    Toh, Sengwee
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 966 - 977
  • [10] La Gamba F, 2017, PHARMACOEPIDEM DR S, V58, P323